▶ 調査レポート

アルテミシニンの世界市場レポート2020

• 英文タイトル:Global Artemisinine Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。アルテミシニンの世界市場レポート2020 / Global Artemisinine Sales Market Report 2020 / QY20ST-05807資料のイメージです。• レポートコード:QY20ST-05807
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥560,000 (USD4,000)▷ お問い合わせ
  Multi User¥840,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,120,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界のアルテミシニン市場について種類別(ホソバニンジン抽出、半合成アルテミシニン)、用途別(注射剤、錠剤、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・アルテミシニン市場の概要
・世界の主要地域別アルテミシニン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のアルテミシニン市場規模2015-2026:種類別(ホソバニンジン抽出、半合成アルテミシニン)
・世界のアルテミシニン市場規模2015-2026:用途別(注射剤、錠剤、その他)
・アルテミシニンの北米市場規模2015-2020
・アルテミシニンのヨーロッパ市場規模2015-2020
・アルテミシニンの中国市場規模2015-2020
・アルテミシニンの日本市場規模2015-2020
・アルテミシニンの東南アジア市場規模2015-2020
・アルテミシニンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・アルテミシニンの製造コスト分析
・販売チャネル、流通業者、顧客
・アルテミシニンの市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Artemisinine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Artemisinine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Artemisinine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Artemisinine industry.
Based on our recent survey, we have several different scenarios about the Artemisinine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Artemisinine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Artemisinine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Artemisinine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Artemisinine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Artemisinine market. The report also includes nautical information, where it shows Artemisinine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Artemisinine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Artemisinine market.
Geographical Analysis:
Based on region, the global Artemisinine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Artemisinine market are
Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinine
Segment by Application
Injections
Tablets
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Artemisinine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Artemisinine market.
• The market share of the global Artemisinine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Artemisinine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Artemisinine market.

レポート目次

1 Artemisinine Market Overview
1.1 Artemisinine Product Scope
1.2 Artemisinine Segment by Type
1.2.1 Global Artemisinine Sales by Type (2020-2026)
1.2.2 Extraction from Artemisia annua
1.2.3 Semisynthetic Artemisinine
1.3 Artemisinine Segment by Application
1.3.1 Global Artemisinine Sales Comparison by Application (2020-2026)
1.3.2 Injections
1.3.3 Tablets
1.3.4 Others
1.4 Artemisinine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Artemisinine Sales Growth Rate (2015-2026)
1.4.2 Global Artemisinine Revenue and Growth Rate (2015-2026)
1.4.3 Global Artemisinine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Artemisinine Industry Impact
1.5.1 How the Covid-19 is Affecting the Artemisinine Industry
1.5.1.1 Artemisinine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Artemisinine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Artemisinine Players to Combat Covid-19 Impact

2 Artemisinine Estimate and Forecast by Region
2.1 Global Artemisinine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Artemisinine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Artemisinine Sales Market Share by Region (2015-2020)
2.2.2 Global Artemisinine Revenue Market Share by Region (2015-2020)
2.3 Global Artemisinine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Artemisinine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Artemisinine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Artemisinine Estimates and Projections (2015-2026)
2.4.2 Europe Artemisinine Estimates and Projections (2015-2026)
2.4.3 China Artemisinine Estimates and Projections (2015-2026)
2.4.4 Japan Artemisinine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Artemisinine Estimates and Projections (2015-2026)
2.4.6 India Artemisinine Estimates and Projections (2015-2026)
3 Global Artemisinine Competition Landscape by Players
3.1 Global Top Artemisinine Players by Sales (2015-2020)
3.2 Global Top Artemisinine Players by Revenue (2015-2020)
3.3 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinine as of 2019)
3.4 Global Artemisinine Average Price by Company (2015-2020)
3.5 Manufacturers Artemisinine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Artemisinine Players (Opinion Leaders)
4 Global Artemisinine Market Size by Type
4.1 Global Artemisinine Historic Market Review by Type (2015-2020)
4.1.1 Global Artemisinine Sales Market Share by Type (2015-2020)
4.1.2 Global Artemisinine Revenue Market Share by Type (2015-2020)
4.1.3 Global Artemisinine Price by Type (2014-2020)
4.2 Global Artemisinine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Artemisinine Sales Forecast by Type (2021-2026)
4.2.2 Global Artemisinine Revenue Forecast by Type (2021-2026)
4.2.3 Global Artemisinine Price Forecast by Type (2021-2026)
5 Global Artemisinine Market Size by Application
5.1 Global Artemisinine Historic Market Review by Application (2015-2020)
5.1.1 Global Artemisinine Sales Market Share by Application (2015-2020)
5.1.2 Global Artemisinine Revenue Market Share by Application (2015-2020)
5.1.3 Global Artemisinine Price by Application (2015-2020)
5.2 Global Artemisinine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Artemisinine Sales Forecast by Application (2021-2026)
5.2.2 Global Artemisinine Revenue Forecast by Application (2021-2026)
5.2.3 Global Artemisinine Price Forecast by Application (2021-2026)

3 North America Artemisinine Market Facts & Figures
3.2 North America Artemisinine Sales Market Share by Company (2015-2020)
3.3 North America Artemisinine Sales Market Share by Type (2015-2020)
3.4 North America Artemisinine Sales Market Share by Application (2015-2020)

4 Europe Artemisinine Market Facts & Figures
4.2 Europe Artemisinine Sales Market Share by Company (2015-2020)
4.3 Europe Artemisinine Sales Market Share by Type (2015-2020)
4.4 Europe Artemisinine Sales Market Share by Application (2015-2020)

5 China Artemisinine Market Facts & Figures
5.2 China Artemisinine Sales Market Share by Company (2015-2020)
5.3 China Artemisinine Sales Market Share by Type (2015-2020)
5.4 China Artemisinine Sales Market Share by Application (2015-2020)

6 Japan Artemisinine Market Facts & Figures
6.2 Japan Artemisinine Sales Market Share by Company (2015-2020)
6.3 Japan Artemisinine Sales Market Share by Type (2015-2020)
6.4 Japan Artemisinine Sales Market Share by Application (2015-2020)

7 Southeast Asia Artemisinine Market Facts & Figures
7.2 Southeast Asia Artemisinine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Artemisinine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Artemisinine Sales Market Share by Application (2015-2020)

8 India Artemisinine Market Facts & Figures
8.2 India Artemisinine Sales Market Share by Company (2015-2020)
8.3 India Artemisinine Sales Market Share by Type (2015-2020)
8.4 India Artemisinine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Artemisinine Business
12.1 Guilin Pharmaceutical
12.1.1 Guilin Pharmaceutical Artemisinine Corporation Information
12.1.2 Guilin Pharmaceutical Artemisinine Business Overview and Total Revenue
12.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Guilin Pharmaceutical Artemisinine Products Offered
12.1.5 Guilin Pharmaceutical Recent Development
12.2 CAT KHANH
12.2.1 CAT KHANH Artemisinine Corporation Information
12.2.2 CAT KHANH Artemisinine Business Overview and Total Revenue
12.2.3 CAT KHANH Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CAT KHANH Artemisinine Products Offered
12.2.5 CAT KHANH Recent Development
12.3 Novanat Bioresource
12.3.1 Novanat Bioresource Artemisinine Corporation Information
12.3.2 Novanat Bioresource Artemisinine Business Overview and Total Revenue
12.3.3 Novanat Bioresource Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novanat Bioresource Artemisinine Products Offered
12.3.5 Novanat Bioresource Recent Development
12.4 BEEPZ
12.4.1 BEEPZ Artemisinine Corporation Information
12.4.2 BEEPZ Artemisinine Business Overview and Total Revenue
12.4.3 BEEPZ Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BEEPZ Artemisinine Products Offered
12.4.5 BEEPZ Recent Development
12.5 KPC Pharmaceuticals
12.5.1 KPC Pharmaceuticals Artemisinine Corporation Information
12.5.2 KPC Pharmaceuticals Artemisinine Business Overview and Total Revenue
12.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 KPC Pharmaceuticals Artemisinine Products Offered
12.5.5 KPC Pharmaceuticals Recent Development
12.6 BIONEXX
12.6.1 BIONEXX Artemisinine Corporation Information
12.6.2 BIONEXX Artemisinine Business Overview and Total Revenue
12.6.3 BIONEXX Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BIONEXX Artemisinine Products Offered
12.6.5 BIONEXX Recent Development
12.7 Guangxi xiancaotang
12.7.1 Guangxi xiancaotang Artemisinine Corporation Information
12.7.2 Guangxi xiancaotang Artemisinine Business Overview and Total Revenue
12.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Guangxi xiancaotang Artemisinine Products Offered
12.7.5 Guangxi xiancaotang Recent Development
12.8 Sanofi
12.8.1 Sanofi Artemisinine Corporation Information
12.8.2 Sanofi Artemisinine Business Overview and Total Revenue
12.8.3 Sanofi Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi Artemisinine Products Offered
12.8.5 Sanofi Recent Development
12.9 Natural Bio-engineering
12.9.1 Natural Bio-engineering Artemisinine Corporation Information
12.9.2 Natural Bio-engineering Artemisinine Business Overview and Total Revenue
12.9.3 Natural Bio-engineering Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Natural Bio-engineering Artemisinine Products Offered
12.9.5 Natural Bio-engineering Recent Development
12.10 Kerui nanhai
12.10.1 Kerui nanhai Artemisinine Corporation Information
12.10.2 Kerui nanhai Artemisinine Business Overview and Total Revenue
12.10.3 Kerui nanhai Artemisinine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Kerui nanhai Artemisinine Products Offered
12.10.5 Kerui nanhai Recent Development

13 Artemisinine Manufacturing Cost Analysis
13.1 Artemisinine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Artemisinine
13.4 Artemisinine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Artemisinine Distributors List
14.3 Artemisinine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Artemisinine Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Artemisinine Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Artemisinine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Artemisinine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Artemisinine Players to Combat Covid-19 Impact
Table 8. Global Market Artemisinine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Artemisinine Sales (K Units) by Region (2015-2020)
Table 10. Global Artemisinine Sales Market Share by Region (2015-2020)
Table 11. Global Artemisinine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Artemisinine Revenue Share by Region (2015-2020)
Table 13. Global Artemisinine Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Artemisinine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Artemisinine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Artemisinine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Artemisinine (K Units) of Key Companies (2015-2020)
Table 18. Global Artemisinine Sales Share by Company (2015-2020)
Table 19. Global Artemisinine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Artemisinine Revenue Share by Company (2015-2020)
Table 21. Global Artemisinine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinine as of 2019)
Table 22. Global Artemisinine Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Artemisinine Manufacturing Sites and Area Served
Table 24. Manufacturers Artemisinine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Artemisinine Players
Table 27. Global Artemisinine Sales (K Units) by Type (2015-2020)
Table 28. Global Artemisinine Sales Share by Type (2015-2020)
Table 29. Global Artemisinine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Artemisinine Price (K Units) by Type (2015-2020)
Table 31. Global Artemisinine Sales Share by Type (2021-2026)
Table 32. Global Artemisinine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Artemisinine Revenue Share by Type (2021-2026)
Table 34. Global Artemisinine Price (K Units) by Type (2021-2026)
Table 35. Global Artemisinine Sales (K Units) by Application (2015-2020)
Table 36. Global Artemisinine Sales Share by Application (2015-2020)
Table 37. Global Artemisinine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Artemisinine Price (K Units) by Application (2015-2020)
Table 39. Global Artemisinine Sales (K Units) by Application (2021-2026)
Table 40. Global Artemisinine Sales Share by Application (2021-2026)
Table 41. Global Artemisinine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Artemisinine Revenue Share by Application (2021-2026)
Table 43. Global Artemisinine Price (K Units) by Application (2021-2026)
Table 44. United States Artemisinine Sales (K Units) by Company (2015-2020)
Table 45. United States Artemisinine Sales Market Share by Company (2015-2020)
Table 46. United States Artemisinine Sales (K Units) by Type (2015-2020)
Table 47. United States Artemisinine Sales Market Share by Type (2015-2020)
Table 48. United States Artemisinine Sales (K Units) by Application (2015-2020)
Table 49. United States Artemisinine Sales Market Share by Application (2015-2020)
Table 50. Europe Artemisinine Sales (K Units) by Company (2015-2020)
Table 51. Europe Artemisinine Sales Market Share by Company (2015-2020)
Table 52. Europe Artemisinine Sales (K Units) by Type (2015-2020)
Table 53. Europe Artemisinine Sales Market Share by Type (2015-2020)
Table 54. Europe Artemisinine Sales (K Units) by Application (2015-2020)
Table 55. Europe Artemisinine Sales Market Share by Type (2015-2020)
Table 56. China Artemisinine Sales (K Units) by Company (2015-2020)
Table 57. China Artemisinine Sales Market Share by Company (2015-2020)
Table 58. China Artemisinine Sales (K Units) by Type (2015-2020)
Table 59. China Artemisinine Sales Market Share by Type (2015-2020)
Table 60. China Artemisinine Sales (K Units) by Application (2015-2020)
Table 61. China Artemisinine Sales Market Share by Application (2015-2020)
Table 62. Japan Artemisinine Sales (K Units) by Company (2015-2020)
Table 63. Japan Artemisinine Sales Market Share by Company (2015-2020)
Table 64. Japan Artemisinine Sales (K Units) by Type (2015-2020)
Table 65. Japan Artemisinine Sales Market Share by Type (2015-2020)
Table 66. Japan Artemisinine Sales (K Units) by Application (2015-2020)
Table 67. Japan Artemisinine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Artemisinine Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Artemisinine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Artemisinine Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Artemisinine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Artemisinine Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Artemisinine Sales Market Share by Application (2015-2020)
Table 74. India Artemisinine Sales (K Units) by Company (2015-2020)
Table 75. India Artemisinine Sales Market Share by Company (2015-2020)
Table 76. India Artemisinine Sales (K Units) by Type (2015-2020)
Table 77. India Artemisinine Sales Market Share by Type (2015-2020)
Table 78. India Artemisinine Sales (K Units) by Application (2015-2020)
Table 79. India Artemisinine Sales Market Share by Application (2015-2020)
Table 80. Guilin Pharmaceutical Corporation Information
Table 81. Guilin Pharmaceutical Description and Business Overview
Table 82. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Guilin Pharmaceutical Artemisinine Product
Table 84. Guilin Pharmaceutical Recent Development
Table 85. CAT KHANH Corporation Information
Table 86. CAT KHANH Description and Business Overview
Table 87. CAT KHANH Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. CAT KHANH Artemisinine Product
Table 89. CAT KHANH Recent Development
Table 90. Novanat Bioresource Corporation Information
Table 91. Novanat Bioresource Description and Business Overview
Table 92. Novanat Bioresource Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novanat Bioresource Artemisinine Product
Table 94. Novanat Bioresource Recent Development
Table 95. BEEPZ Corporation Information
Table 96. BEEPZ Description and Business Overview
Table 97. BEEPZ Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. BEEPZ Artemisinine Product
Table 99. BEEPZ Recent Development
Table 100. KPC Pharmaceuticals Corporation Information
Table 101. KPC Pharmaceuticals Description and Business Overview
Table 102. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. KPC Pharmaceuticals Artemisinine Product
Table 104. KPC Pharmaceuticals Recent Development
Table 105. BIONEXX Corporation Information
Table 106. BIONEXX Description and Business Overview
Table 107. BIONEXX Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. BIONEXX Artemisinine Product
Table 109. BIONEXX Recent Development
Table 110. Guangxi xiancaotang Corporation Information
Table 111. Guangxi xiancaotang Description and Business Overview
Table 112. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Guangxi xiancaotang Artemisinine Product
Table 114. Guangxi xiancaotang Recent Development
Table 115. Sanofi Corporation Information
Table 116. Sanofi Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Sanofi Description and Business Overview
Table 118. Sanofi Artemisinine Product
Table 119. Sanofi Recent Development
Table 120. Natural Bio-engineering Corporation Information
Table 121. Natural Bio-engineering Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Natural Bio-engineering Description and Business Overview
Table 123. Natural Bio-engineering Artemisinine Product
Table 124. Natural Bio-engineering Recent Development
Table . Kerui nanhai Corporation Information
Table . Kerui nanhai Description and Business Overview
Table . Kerui nanhai Artemisinine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Kerui nanhai Artemisinine Product
Table . Kerui nanhai Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Artemisinine Distributors List
Table 133. Artemisinine Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Artemisinine Product Picture
Figure 2. Global Artemisinine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Artemisinine Market Share by Application in 2020 & 2026
Figure 6. Injections Examples
Figure 7. Tablets Examples
Figure 8. Others Examples
Figure 9. Global Artemisinine Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Artemisinine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Artemisinine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Artemisinine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Artemisinine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Artemisinine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Artemisinine Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Artemisinine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Artemisinine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Artemisinine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Artemisinine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Artemisinine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Artemisinine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Artemisinine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Artemisinine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Artemisinine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Artemisinine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Artemisinine Players Market Share by Revenue in Artemisinine 2015 & 2019
Figure 27. Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Artemisinine Revenue Share by Type (2015-2020)
Figure 29. Global Artemisinine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Artemisinine Revenue Share by Application (2015-2020)
Figure 31. Global Artemisinine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Artemisinine Sales Market Share by Type in 2019
Figure 33. United States Artemisinine Sales Market Share by Type in 2019
Figure 34. Europe Artemisinine Sales Market Share by Company in 2019
Figure 35. Europe Artemisinine Sales Market Share by Type in 2019
Figure 36. Europe Artemisinine Sales Market Share by Application in 2019
Figure 37. China Artemisinine Sales Market Share by Company in 2019
Figure 38. China Artemisinine Sales Market Share by Type in 2019
Figure 39. China Artemisinine Sales Market Share by Application in 2019
Figure 40. Japan Artemisinine Sales Market Share by Company in 2019
Figure 41. Japan Artemisinine Sales Market Share by Type in 2019
Figure 42. Japan Artemisinine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Artemisinine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Artemisinine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Artemisinine Sales Market Share by Application in 2019
Figure 46. India Artemisinine Sales Market Share by Company in 2019
Figure 47. India Artemisinine Sales Market Share by Type in 2019
Figure 48. India Artemisinine Sales Market Share by Application in 2019
Figure 49. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. CAT KHANH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novanat Bioresource Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. BEEPZ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. KPC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. BIONEXX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Guangxi xiancaotang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Natural Bio-engineering Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Kerui nanhai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Artemisinine
Figure 61. Manufacturing Process Analysis of Artemisinine
Figure 62. Artemisinine Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed